Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for June 2010
June 3, 2010
- United Spinal Association Teams Up With Botox Maker Allergan and Actor Henry Winkler to Launch 'Open Arms: Raising Awareness of Upper Limb Spasticity' Educational Campaign
- FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's Symbicort
- GSK Announces Revised Product Labels for Serevent and Advair
- Elan Corporation, plc Board Announces CEO Agreement
June 4, 2010
- Ascenta Therapeutics Licenses Cancer Drug Candidates to sanofi-aventis
- Pfizer Initiates A Nationwide Voluntary Recall Of All Lots Of Metronidazole Injection, Ciprofloxacin Injection, And Ondansetron Injection Bags Made By Claris Lifesciences Due To Non-Sterility
- Troubled KV Sells Unit For $24 Million
- Novartis' Afinitor Meets Cancer Study Goals
- Novella Acquires Prologue
- Millipore Shareholders Approve Acquisition by Merck KGaA
June 7, 2010
- Grifols to Acquire Talecris Biotherapeutics Creating a World Leading Provider of Life-Saving Plasma Protein Therapies
- Exiqon is closing down operations at Oncotech, Inc.
- Genzyme Adds Fenton To Board, Expands to 11
- Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Talecris Biotherapeutics Holdings Corp. - TLCR
June 8, 2010
- Biogen Idec Provides Update on CEO Search and Management Changes
- Forest Laboratories and TransTech Pharma Enter Into License Agreement for the Development and Commercialization of Glucokinase Activators with Deal Valued at Up to $1.105 Billion
- WHO: Pharma Interests Didn't Influence Flu Verdict
- USGS: Drug Companies Cause Water Pollution
- Manufacturing Facilities Release Pharmaceuticals to the Environment
- Dr. Michael D. Ehlers, Distinguished Neurobiologist, Joins Pfizer
June 9, 2010
- FDA Weighs Benefits, Risks Of Novartis MS drug
- Pfizer Leads The Way With Free Samples
- Depomed Says FDA Will Review Drug candidate
- Celldex Says Skin Cancer Drug Meets Study goal
- NICE Rules Against NHS Funding For Tyverb (Lapatinib), An Effective Treatment For Advanced Breast Cancer
- Genzyme and Carl Icahn Reach Agreement
- Duke University Researcher To Head Pfizer Neuroscience Unit in Groton
- Astellas Completes Acquisition of OSI Pharmaceuticals
June 10, 2010
- US Government Warns Pfizer About Failing to Report Drug Side-Effect Reports
- Onset Therapeutics Announces Continued Commercial Expansion and Pipeline Progress
- Ranbaxy Launches Antiplatelet Agent Prasugrel in India
- Canada Health Warnings for Pfizer Smoking Cessation Drug Champix
- Cardinal Buys Entry To Specialty Medicines [The Columbus Dispatch, Ohio]
- UCB (BE) - UCB strengthens strategic alliance with WILEX
- UCB Takes Further 6.65% In German Oncology Partner Wilex
June 11, 2010
- FDA Lifts Full Clinical Hold on Repros' Proellex
- Hospira Brand Liposyn and Propofol: Recall
- Senator Tells University Of Miami He's 'Troubled' Over Hiring
- Pa. Faces Off Against Drug Firm In Court
- First Combined Pharma Trial Data on Brain Disease Made Widely Available to Researchers Today
- Blue Cross Blue Shield Of Texas Sues Pfizer, Saying Drug Maker Marketed Three Drugs Deceptively
- Gilead Says Lupin Challenges Ranexa patents
- KV Pharmaceutical Company Announces New Board Members and Restructuring of Senior Executive Management
- FDA MedWatch - Benicar (olmesartan) Ongoing Safety Review - FDA evaluating data in which type 2 diabetes patients taking Benicar had a higher rate of death from cardiovascular cause compared to placebo. FDA has not concluded that Benicar increases the ...
June 14, 2010
- FDA Drug Safety Communication: Ongoing Safety Review of Benicar and Cardiovascular Events
- Blood Pressure Pills Could Raise Cancer Risk
- Texas Blue Cross Plan Sues Pfizer Over Marketing
- NICE Appraisal of liraglutide for Type 2 Diabetes Mellitus
June 15, 2010
- Pfizer Probed By House Oversight Committee
- Trubion Provides Update on Clinical Development in RA
- Genzyme Prices Private Senior Notes Offerings
- FDA Seeks To Ban Chicago HIV Doctor From Research
- Trubion: Pfizer Cancels Rheumatoid Arthritis Drug
- Genzyme's MS Drug Gets FDA Fast Track
- PPD and Furiex Announce Completion of Spin-Off
- The New Health Report Reveals Perception Gaps Among Biopharma Stakeholders
- Patients Can Have Greater Influence on Success, Failure of New Drugs, Quintiles Report Reveals
- Genmab announces Change in Management
June 16, 2010
- Teva Prices $2.5 Billion In Notes In Offering
- Drug Firms Banished From Medical Talks
- GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
- Abbott, Neurocrine Developing Gynecological Drug
- Drug Developer Furiex Debuts
- Genvec Says It Is Considering Strategic Options
- PDL Expects 2Q Sales Decline On Royalty Dispute
- Merck Serono To Expand Israel Operations
- Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis
June 17, 2010
- Durect Says Pain Drug Meets 1 Of 2 Study Goals
- Genzyme Names New Directors, Ending Icahn Dispute
- FDA Sends Letters to Companies for Misbranding and Marketing Unapproved Drugs
- Shareholders Re-Elect All Members of Genzyme's Board of Directors
- Merck KGaA Resumes Stimuvax Clinical Program in Lung Cancer
- Bayer Schering Pharma and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
- Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals
- Abbott Vascular Lays Off Workers
- DURECT Reports Data From European Phase IIb Hysterectomy Study of Posidur (SABER-Bupivacaine)
- U.S. Health Regulators Question Effectiveness of Female Libido Pill
June 18, 2010
- Astrazeneca Reviewing Its Options After Canadian Court Ruling Paves Way for Nexium Rival
- FDA Warns About Fraudulent Tamiflu
- Alkermes: FDA Panel Will Review Vivitrol In Sept.
- Mylan Meeting Under SEC Probe
- Genzyme Announces Accelerated Share Repurchase
- Teva Announces Completion of $2.5 Billion of Senior Notes Offering
- PharmaLive.Com Releases 2010 First Quarterly People On The Move Report For Healthcare Manufacturers And Supporting Companies
June 21, 2010
- Astrazeneca Settles Suit For $103 Million
- Pfizer Canada Inc. Provides Status on Lipitor Continuity Card Program in Quebec
- Valeant and Biovail Agree to Merge
- Exelixis Regains Full Rights to Develop and Commercialize XL184
- Amylin Lays Off 60 For Efficiency
- Astrazeneca Settles Suit For $103 Million
- Apotex Says It's Too Soon To Comment On Court Ruling In Nexium Patent Battle
- FDA Grants Approval For APP Pharmaceuticals Drug
- FDA: Pfizer Voluntarily Withdraws Cancer Treatment Mylotarg From U.S. Market
June 22, 2010
- Cancer Drug Removed From U.S. Market
- Many Clinicians Maintain Positive Attitudes Toward Industry Marketing Activities
- Regulus, Sanofi-Aventis Team Up In $750M Alliance
- Johnson & Johnson In Deal For Type 1 diabetes drug
June 23, 2010
- FDA: Termination of Declarations of Emergency Justifying Emergency Use Authorization (EUA) of Certain Antiviral Drugs - Zanamivir, Oseltamivir Phosphate, and Peramivir
- Prosensa and GlaxoSmithKline Initiate Development of Four Additional Products under Existing Alliance in Duchenne Muscular Dystrophy
- Report: FDA Struggles to Track Foreign Drug trials
- Takeda to Expand Presence in Asia with Operations in South Korea
- Announcement of Whitepaper on FDA REMS
- febit Announces Operational Restructuring
June 24, 2010
- Pfizer Halts Studies on Osteoarthritis Drug
- Merck to Expand Business in South Africa
- Abbott Enters Final Clinical Trial Of MS Drug
- New Route To Killing Cancer Tried
- Pfizer Suspends Tanezumab Osteoarthritis Clinical Trial Program
- Lilly Set To Plunge Into Cholesterol Drug Market
- Ogilvy & Mather and CommonHealth to Merge their Healthcare Business: New Global Powerhouse Created
June 25, 2010
- J&J Won't Have Supplies for Recalled Meds in 2010
- Gilead Sciences to Acquire CGI Pharmaceuticals for up to $120 Million
- Alternate Drugs Not Always Identical
- Biotech Firm To Phase Out 150 Jobs
- Agency's Demise Spawns Startup
- Mass. House Proposes Lifting Ban On Industry Gifts to Doctors
- A Look At Recent Failures In Pfizer Drug Research
- BRIEF: Lilly, Walmart To Sell Co-Branded Insulin
- Latest Pfizer Drug Failure Shows Worrisome Trend
- Sanofi-aventis and Metabolex enter into an Exclusive Worldwide Licensing Agreement for a Novel Oral Antidiabetic to treat Type II Diabetes
June 28, 2010
- Researcher Sentenced For Faking Drug Tests: Pfizer to Receive Compensation in Reuben Sentencing
- Swiss Corporate Governance Expert Supports Alcon Independent Director Committee's Position against Novartis
- Merck Challenges Verdict in Federal Fosamax (alendronate sodium) Trial
- Shire Braced for US Study Into Risks Of Attention Deficit Drug
- Former Johnson & Johnson CEO Dies
- Researcher Sentenced for Faking Drug Tests
- Amylin Shares Rise Following Analyst Upgrade
- Big Pharma Relying On Old Lines Of Drugs, Report Says
- Bristol-Myers/Astrazeneca Diabetes Drug Meets Goal
June 29, 2010
- GlaxoSmithKline Declines After Studies Show Heart Risk in Diabetes Drug
- For Diabetes Drug Avandia, Bad News Continues
- Theraclone Makes a'First Step' on Long Road to Universal Flu Vaccine
- ACCME Reverses Ban Drug Firms' Presentations
- Abbott to Sell Flu Vaccine Business
- US Court Rejects Pfizer Appeal Of Nigerians' Case
June 30, 2010
- Celgene to Acquire Abraxis BioScience Inc.
- Astrazeneca Shares Surge on Court Victory
- Sanofi-Aventis Says Buying US TargeGen For Up To USD560 Million
- Crestor Patent Upheld By US Court
- Sanofi-Aventis to Acquire Targegen Inc., A US Biopharmaceutical Company
- Merck Wins Case Filed by Louisiana Attorney General Involving Vioxx
- Kowa Pharmaceuticals America and Lilly Announce U.S. Availability of Livalo
